Comparison of two valved holding chambers for the delivery of an HFA-based solution corticosteroid formulation

M. W. Nagel, C. C. Doyle, S. L. Bates, J. P. Mitchell (London, Canada)

Source: Annual Congress 2002 - Lung disposition clinical outcomes: effect of delivery device
Session: Lung disposition clinical outcomes: effect of delivery device
Session type: Thematic Poster Session
Number: 3129
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. W. Nagel, C. C. Doyle, S. L. Bates, J. P. Mitchell (London, Canada). Comparison of two valved holding chambers for the delivery of an HFA-based solution corticosteroid formulation. Eur Respir J 2002; 20: Suppl. 38, 3129

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019

Antistatic treatment and the amount of salbutamol actuated have variable effect on drug delivery of six different valved holding chambers (VHC)
Source: International Congress 2019 – Severe acute asthma and troublesome wheezing
Year: 2019

In vitro delivery of an HFA-based corticosteroid by pediatric and adult valved holding chambers (VHC): effect of inhalation flow rate
Source: Eur Respir J 2002; 20: Suppl. 38, 500s
Year: 2002

Effect of device and formulation on delivery of budesonide suspensions by nebulizers
Source: Eur Respir J 2002; 20: Suppl. 38, 542s
Year: 2002

In vitro performance of a small non-electrostatic valved holding chamber made from metal with three different brands of pressurized metered dose inhalers
Source: Eur Respir J 2006; 28: Suppl. 50, 712s
Year: 2006

Delivery of medication via a novel non-electrostatic valved holding chamber (VHC) for infant use depends on the number of inhalations
Source: Eur Respir J 2006; 28: Suppl. 50, 713s
Year: 2006

Inhaled corticosteroid fine particle dose from valved holding chambers
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010


In vitro testing of an improved collapsible valved holding chamber (CHC) with a pressurized metered-dose inhaler delivered bronchodilator, simulating an adult mechanically ventilated patient
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010


Priming of a non-conducting valved holding chamber (VHC) is formulation dependent and may result in inconsistent medication delivery
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007


A small volume valved holding chamber (VHC) manufactured from charge dissipative materials has comparable in vitro performance with a large volume non-conducting plastic spacer for both bronchodilator and anti-inflammatory formulations
Source: Eur Respir J 2005; 26: Suppl. 49, 340s
Year: 2005

Feedback during treatment results in increased adherence when using a pressurized metered dose inhaler with valved holding chamber in paediatric patients with asthma
Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children
Year: 2008

Not all antistatic valved holding chambers have equivalent performance: An example why each valved holding chamber (VHC)-inhaler combination should be considered unique
Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs
Year: 2012


Laboratory assessment of drug delivery of Beclomethasone/Formoterol metered dose inhaler (MDI) with a new valved holding chamber (VHC) designed specifically for 'on-the-go' use.
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021


Impact of inspiratory delay and valved holding chamber (VHC) material on drug delivery
Source: Eur Respir J 2001; 18: Suppl. 33, 494s
Year: 2001

Effect of the actuator orifice diameter on the biodisposition of a new budesonide CFC-free metered dose inhaler formulation
Source: Eur Respir J 2001; 18: Suppl. 33, 102s
Year: 2001

Assessment of the suitability of filters for use in clinical studies with an HFA fluticasone propionate pressurized metered dose inhaler (pMDI) and a valved holding chamber (VHC)
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011

In vitro comparison of aerosol characteristics of HFA albuterol (salbutamol) pressurized metered dose inhaler (pMDI) formulation from three valved holding chambers (VHCs)
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011

Bioequivalence of a new formulation of omalizumab, solution for injection in prefilled syringe, to the current lyophilized formulation
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


In vitro equivalence exists for infant non-conducting (NC) and anti-static (AS) valved holding chambers (VHC) from the same family of add on devices used with pressurized metered dose inhalers (pMDIs) provided pre-conditioning of the non-conducting VHCs is undertaken
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010


Valved holding chamber (VHC) angle can affect pressurized netered-dose inhaler (pMDI) medication delivery efficiency
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018